Interestingly, the degradation enzyme for retinoic acid encoded by the CYP26B1 gene harbors significant number of PDRVs in craniorachischisis cases (2/19 in craniorachischisis vs. 0/225 in all controls; P = 0.007; Fig. 3b and c). Here, CYP26B1 is linked to craniorachischisis.